Atlas Trials

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

Clinical trial NCT06338956 · COMPLETED

Trial details

NCT number
NCT06338956
Sponsor
Samsung Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Artery DiseaseHyperlipidemias
Start date
2024-01-01
Primary completion
2024-12-31
Enrollment
135877

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.